Air Liquide, established in 1902 and headquartered in Paris, France, is a world leader in gases, technologies, and services for industry and healthcare. The company operates in 60 countries with approximately 66,500 employees, serving over 4 million customers and patients. Air Liquide's offerings include industrial gases (such as oxygen, nitrogen, and hydrogen), medical gases, and related services. Committed to innovation and sustainability, the company focuses on developing solutions to address environmental and energy challenges.
The upgraded Yulin oxygen facility will increase output and sharply cut emissions by replacing steam-driven operation with an electric system powered by low-carbon energy.
The renewed partnership strengthens global hydrogen infrastructure, mobility deployment and supply chains across Europe, the U.S. and South Korea to accelerate the energy transition.
With two MAN hydrogen-combustion trucks in collaboration with Schenk Tanktransport, Air Liquide reduces CO₂ emissions in Greater Rotterdam, backed by the Dutch SWiM funding scheme.
Air Liquide debuted the world's first industrial-scale ammonia cracking pilot unit, demonstrating a key technology to convert ammonia into hydrogen at 30 tons per day, enabling a low-carbon global supply chain.
Air Liquide Healthcare's ECO ORIGIN offers certified low-carbon medical gases, reducing carbon footprints by over 70%, using renewable energy, optimized delivery, and alternative fuels.
Air Liquide has received EU support to develop the first large-scale project for the production, liquefaction, and distribution of low-carbon and renewable hydrogen from ammonia.